- ￥5000
- GeneTex
- 美国
- GTX55612
- 2025年07月12日
- WB, IHC-P
- Rabbit
- Human, Mouse, Rat
企业认证
相关产品推荐更多 >
![MYL4 antibody [AT4E8]](https://img1.dxycdn.com/2022/0328/961/1668619630410500453-14.jpg!wh200)
![DRP1 antibody [4E11B11]](https://img1.dxycdn.com/2022/0328/372/8390736435443500453-14.jpg!wh200)
![HCLS1 antibody [N1N3]](https://img1.dxycdn.com/2022/0328/159/1664226295050300453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant fusion protein containing a sequence corresponding to amino acids 29-192 of human F9 (NP_000124.1).
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Mouse, Rat
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX55612
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Rabbit
- 应用范围：
WB, IHC-P
- 浓度：
Batch dependent (Please refer to the vial label for the specific concentration.)
- 靶点：
Factor IX
- 抗体英文名：
Factor IX antibody
- 抗体名：
Factor IX 抗体
- 规格：
100 μl
IHC-P analysis of rat liver tissue using GTX55612 Factor IX antibody.
Blue : DAPI
Dilution : 1:100
WB analysis of human plasma lysate using GTX55612 Factor IX antibody.
Dilution : 1:1000
Loading : 25μg per lane
IHC-P analysis of human placenta tissue using GTX55612 Factor IX antibody.
Blue : DAPI
Dilution : 1:100
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Yang L et al., Oncotarget 2018 (PMID:29464022)
Factor IX Gene Therapy for Hemophilia
Using gene therapy to produce systemic levels of human factor IX for the treatment of hemophilia B has been clinically evaluated using viral-based vectors. The efficacy of this approach has been limited because of immune responses
Ex Vivo Stromal Cell Electroporation of Factor IX cDNA for Treatment of Hemophilia B
Hemophilia B is an X-linked genetic disorder that typically results from chronic circulating deficiency of blood coagulation factor IX (FIX) (1). While the occurrence of hemophilia B is significantly less frequent than hemophilia A (factor
Identification of Mutations in the Human Factor VII Gene
It has been recognized from the early 1800s that activation of coagulation can be initiated by the exposure of subendothelial layers (tissue factor), but it was the 1940s before factor VII (FVII) was included in this event
技术资料暂无技术资料 索取技术资料
